Registration for a live webinar on 'Innovative Vaccines and Viral Pathogenesis: Insights from Recent Monkeypox (Mpox) Research' is now open.
See webinar detailsWe noted you are experiencing viewing problems
-
Check with your IT department that JWPlatform, JWPlayer and Amazon AWS & CloudFront are not being blocked by your network. The relevant domains are *.jwplatform.com, *.jwpsrv.com, *.jwpcdn.com, jwpltx.com, jwpsrv.a.ssl.fastly.net, *.amazonaws.com and *.cloudfront.net. The relevant ports are 80 and 443.
-
Check the following talk links to see which ones work correctly:
Auto Mode
HTTP Progressive Download Send us your results from the above test links at access@hstalks.com and we will contact you with further advice on troubleshooting your viewing problems. -
No luck yet? More tips for troubleshooting viewing issues
-
Contact HST Support access@hstalks.com
-
Please review our troubleshooting guide for tips and advice on resolving your viewing problems.
-
For additional help, please don't hesitate to contact HST support access@hstalks.com
We hope you have enjoyed this limited-length demo
This is a limited length demo talk; you may
login or
review methods of
obtaining more access.
Printable Handouts
Navigable Slide Index
- Introduction
- Outline
- What are polymers?
- Polymers, macromolecules, nanoparticles
- Evolution of polymers
- Polymers as nanocarriers
- Nanotransporters for biomedical applications
- Nanocarriers architecture
- Mechanism of drug delivery
- Responsive modalities
- Building blocks
- What happens to soluble polymers in vivo? (1)
- Delivery barriers
- Specific functions of the skin as a barrier
- Nanobiointerface
- Biological identity and physical response
- Distribution of polymeric materials in the body
- Targeting
- What happens to soluble polymers in vivo? (2)
- Controlling delivery with architecture
- Controlling delivery with architecture: examples
- Membrane-associated targets
- Challenges on anticancer treatments
- Development of labile PG-drug conjugates
- Modular synthetic approach
- Efficacy of different PG-DOXO-EMCH conjugates
- Skin as a biological barrier
- Triggered release modality
- Thermoresponsive nanogels
- Thermoresponsive NGs by polymerization
- Skin penetration mechanisms
- Topical delivery of biomacromolecules
- Polymeric nanoparticles for hair follicle penetration
- Controlled topical drug delivery
- Summary
Topics Covered
- Definition and introduction of polymers as nanocarriers
- Mechanisms and triggers for controlled drug delivery
- Biological fate of polymeric nanocarriers
- The use of polymer-drug conjugates for anticancer therapy
- Examples of thermoresponsive nanogels and polymeric nanoparticles for hair follicle penetration for topical drug delivery
Talk Citation
Calderón, M. (2018, November 29). Polymers as nanocarriers for controlled drug delivery [Video file]. In The Biomedical & Life Sciences Collection, Henry Stewart Talks. Retrieved November 21, 2024, from https://doi.org/10.69645/HEMK8626.Export Citation (RIS)
Publication History
Financial Disclosures
- Prof. Dr. Marcelo Calderón has not informed HSTalks of any commercial/financial relationship that it is appropriate to disclose.
Other Talks in the Series: Drug Delivery
Transcript
Please wait while the transcript is being prepared...
0:00
Hi, my name is Marcelo Calderon.
I'm Professor for Organic and
Macromolecular Chemistry at the Freie Universität Berlin in Germany,
and I'm an Ikerbasque Research Professor in Polymers
for Biomedicine in POLYMAT, San Sebastian, Spain.
Today, we'll be talking to you about polymers
as nanocarriers for controlled drug delivery.
0:19
As an outline, I would like to go over the topics from today's talk.
First, we will get started with the definition of polymers and their use as nanocarriers.
Later, we will move to discuss the mechanisms
that it could be used for drug delivery using polymers,
which kind of triggers could we use for
controlling the drug delivery at the site of action.
Moreover, we will discuss how
the different properties of
the polymeric nanocarriers could influence their biological fate,
and we will finalize our presentation from today by discussing
some examples regarding the development
of polymer-drug conjugates for anticancer therapy,
the development of thermoresponsive nanogels for topical drug delivery,
and moreover, the use of polymeric nanoparticles for hair follicle penetration.
At the end, we will close the talk with a summary.
1:09
So the first question we have for today is what are polymers.
So, polymers, as has been defined by
the International Union of Pure and Applied Chemistry,
are substances compose of macromolecules.
They're very large, with high molecular weights ranging
from few thousands to as high as millions of gram per mole.
The IUPAC defined polymers as molecules of high relative molecular mass.
Their structure is essentially comprised by a multiple repetition of units
derived mostly by molecules from relatively low molecular mass.
There are different kind of polymers.
There are natural polymers and synthetic polymers.
And, for sure, you know already some of natural polymers.
There are proteins, starch, cellulose, and DNA.
And from synthetic polymers, for sure,
you know some of them that you may use when you go to supermarket.
Like, for instance, nylon,
polyethylene, and many others.
So now, the question we have for today's discussion
is how these polymers can be used for controlled drug delivery.